Product logins

Find logins to all Clarivate products below.


Peripheral Vascular Devices – Market Insights – Asia Pacific (Supplemental)

The Asia Pacific PV device market will grow modestly over the forecast period, driven by the high prevalence of PAD, expanding PAD-related comorbidities, and rising adoption of premium-priced drug-eluting products. Rising procedure volumes for iliac and lower limb indications and the increasing adoption of endovascular techniques over surgical intervention will also fuel market growth, particularly in China. However, cost constraints in publicly funded healthcare systems and limited reimbursement in the region continue to hinder the adoption of premium-priced devices and limit the pace of revenue expansion.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for PV devices in the Asia Pacific region from 2019 through 2033.

Table of contents


Related Medtech Insights Reports

Report
Gynecological Devices – Market Insights – Europe
The European gynecological device market will see marginal growth over the forecast period, fueled by the ongoing adoption of office-based treatments, the increasing preference for minimally…
Report
Sports Medicine Devices – Market Insights – Japan
Technological investments, adoption of premium-priced products, increased market awareness through educational programs, improved surgeon training, and high levels of sports participation will…
Report
Diagnostic Imaging Systems – Market Insights – China
The diagnostic imaging system market in China will see moderate growth in the overall diagnostic imaging space through 2034, driven by favorable demographic trends and the accelerating adoption of…
Report
Urological Devices – Market Insights – Europe
The European urological device market is set to grow through 2034, driven by product innovation, rising awareness, increasing kidney stone cases, and an aging population. Growth will be led by BPH…
Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…